Translational Development Acquisition Corp.’s (NASDAQ:TDACU) Quiet Period Set To Expire on February 3rd

Translational Development Acquisition’s (NASDAQ:TDACU) quiet period will expire on Monday, February 3rd. Translational Development Acquisition had issued 15,000,000 shares in its initial public offering on December 23rd. The total size of the offering was $150,000,000 based on an initial share price of $10.00. During the company’s quiet period, insiders and underwriters that worked on the IPO are restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Translational Development Acquisition Price Performance

TDACU stock opened at $10.05 on Friday. Translational Development Acquisition has a 52 week low of $10.00 and a 52 week high of $10.05.

Hedge Funds Weigh In On Translational Development Acquisition

A hedge fund recently bought a new stake in Translational Development Acquisition stock. Calamos Advisors LLC acquired a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACU) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 375,000 shares of the company’s stock, valued at approximately $6,915,000.

About Translational Development Acquisition

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.